THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,012 | -5.7% | 117,318 | +13.2% | 0.01% | +11.1% |
| Q2 2023 | $1,073 | -99.8% | 103,681 | +92.5% | 0.01% | +28.6% |
| Q1 2022 | $515,000 | +372.5% | 53,850 | +264.1% | 0.01% | +600.0% |
| Q3 2021 | $109,000 | -91.7% | 14,791 | -83.7% | 0.00% | -93.3% |
| Q2 2021 | $1,319,000 | +383.2% | 90,864 | +391.9% | 0.02% | +200.0% |
| Q3 2020 | $273,000 | -58.6% | 18,472 | -41.2% | 0.01% | -70.6% |
| Q2 2020 | $659,000 | – | 31,405 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |